최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of clinical pharmacy and therapeutics, v.46 no.3, 2021년, pp.814 - 819
Ji, Wei (Department of Clinical Research Center, Jinan Central Hospital Affiliated to Shandong University, Jinan, China) , Yang, Shaomei (Department of Clinical Research Center, Jinan Central Hospital Affiliated to Shandong University, Jinan, China) , Zhang, Wenyu (Department of Clinical Research Center, Jinan Central Hospital Affiliated to Shandong University, Jinan, China) , Sun, Zhongliang (Shanghai LingXian Medical Consulting CO., LTD, Jinan, China) , Wen, Qing (Department of Clinical Research Center, Jinan Central Hospital Affiliated to Shandong University, Jinan, China) , He, Kun (Department of Clinical Research Center, Jinan Central Hospital Affiliated to Shandong University, Jinan, China)
AbstractWhat is known and objectiveAcarbose can efficiently block glucose absorption in the intestine as an alpha‐glucosidase inhibitor. It is currently manufactured in several oral dosage forms, with the most common types being tablets and chewable tablets. The acarbose tablet (Glucobay®,...
Zhang, Min, Yang, Jin, Tao, Lei, Li, Lingjun, Ma, Pengcheng, Fawcett, John Paul. Acarbose Bioequivalence: Exploration of New Pharmacodynamic Parameters. The AAPS journal, vol.14, no.2, 345-351.
Jiang, Jiebing, Li, Jiajia, Zhu, Jinglin, Yu, Yingjia, Duan, Gengli, Zhou, Ligang, Li, Yan. Synthesis of sandwich-structured magnetic graphene-Zn-MOFs composites for quantitative determination of acarbose in rat plasma. Talanta, vol.209, 120514-.
Fang, Hui, Xu, Fengmei, Du, Jin, Liang, Li, Li, Wei, Shen, Liya, Wang, Xueying, Xu, Chun, Bian, Fang, Mu, Yiming. Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus. Journal of diabetes investigation, vol.11, no.4, 896-905.
Pishdad, Reza, Pishdad, Parisa, Pishdad, Gholam Reza. Acarbose versus Repaglinide in Diabetes Treatment: A New Appraisal of Two Old Rivals. The American journal of the medical sciences, vol.359, no.4, 212-217.
Ghabi, Ameni, Brahmi, Jihed, Alminderej, Fahad, Messaoudi, Sabri, Vidal, Sébastien, Kadri, Adel, Aouadi, Kaïss. Multifunctional isoxazolidine derivatives as α-amylase and α-glucosidase inhibitors. Bioorganic chemistry, vol.98, 103713-.
Gerstein, Hertzel C., Coleman, Ruth L., Scott, Charles A.B., Xu, Shishi, Tuomilehto, Jaakko, Rydén, Lars, Holman, Rury R.. Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial. Diabetes care, vol.43, no.9, 2242-2247.
Dodds, Sherry G., Parihar, Manish, Javors, Martin, Nie, Jia, Musi, Nicolas, Dave Sharp, Zelton, Hasty, Paul. Acarbose improved survival for Apc+/Min mice. Aging cell, vol.19, no.2, e13088-.
Hanefeld, Markolf, Schaper, Frank. Acarbose: oral antidiabetes drug with additional cardiovascular benefits. Expert review of cardiovascular therapy, vol.6, no.2, 153-163.
Hanefeld, Markolf, Schaper, Frank, Koehler, Carsta. Effect of Acarbose on Vascular Disease in Patients with Abnormal Glucose Tolerance. Cardiovascular drugs and therapy, vol.22, no.3, 225-231.
Wu, Qian Lin, Liu, Yu Ping, Lu, Ju Ming, Wang, Chang Jiang, Yang, Tao, Dong, Ji Xiang, Li, Cheng Jiang, Ma, Jian Hua, Xue, Yao Ming, Sun, Rui Hua, Wei, Dong, Tian, Hao Ming. Efficacy and safety of acarbose chewable tablet in patients with type 2 diabetes: a multicentre, randomized, double‐blinded, double‐dummy positive controlled trial. Journal of evidence-based medicine, vol.5, no.3, 134-138.
Pharmazie Debeljak J 566 71 2016 Randomised, double blind, cross‐over, placebo and active controlled human pharmacodynamic study on the influence of silver fir wood extract (Belinal) on post‐prandial glycemic response
Kim, S., Jang, I.‐J., Shin, D., Shin, D. S., Yoon, S., Lim, K. S., Yu, K.‐S., Li, J., Zhang, H., Liu, Y., Brendel, E., Blode, H., Wang, Y.. Investigation of bioequivalence of a new fixed‐dose combination of acarbose and metformin with the corresponding loose combination as well as the drug–drug interaction potential between both drugs in healthy adult male subjects. Journal of clinical pharmacy and therapeutics, vol.39, no.4, 424-431.
Lee, S., Chung, J. Y., Hong, K. S., Yang, S.‐H., Byun, S.‐Y., Lim, H.‐S., Shin, S.‐G., Jang, I.‐J., Yu, K.‐S.. Pharmacodynamic comparison of two formulations of Acarbose 100‐mg tablets. Journal of clinical pharmacy and therapeutics, vol.37, no.5, 553-557.
Food and Drug Administration (FDA).Guidance on Acarbose 2017. Available athttps://www.accessdata.fda.gov/drugsatfda_docs/psg/Acarbose_oral%20tablet_NDA%2020482_final%2008‐17.pdf. Accessed January 4 2021.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.